Indole lactate for the treatment of multiple sclerosis
AssigneeThe Johns Hopkins University
InventorsPavan Bhargava, Peter A. Calabresi, Michael D. Kornberg, Kathryn Fitzgerald
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Johns Hopkins University
InventorsPavan Bhargava, Peter A. Calabresi, Michael D. Kornberg, Kathryn Fitzgerald
Estimating the term…
The use of indole lactate for treating Multiple Sclerosis is disclosed. Methods herein include a method for treating multiple sclerosis (MS) in a subject in need of treatment thereof, the methods enclosed herein comprise administering to the subject a therapeutically effective amount of indole lactate or indole-3-lactic acid. In certain aspects, administration of indole lactate or indole-3-lactic acid repairs demyelination of neurons and reduces inflammation in the subject with MS. In certain aspects, the administering comprises oral or intravenous administration. In certain aspects, the MS is selected from relapsing-remitting MS, secondary progressive MS, primary-progressive MS, and progressive-relapsing MS. In particular aspects, the MS is relapsing-remitting MS or secondary¬progressive MS.
A method for treating multiple sclerosis (MS) in a subject in need of treatment thereof, the method comprising administering to the subject a therapeutically effective amount of indole lactate.
Dependencies are inferred from the claim text.